AnaptysBio, Inc. (ANAB) Covered Calls
You can sell covered calls on AnaptysBio, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ANAB (prices last updated Fri 4:16 PM ET):
| AnaptysBio, Inc. (ANAB) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 21.00 | +2.13 | 15.00 | 33.56 | 642K | - | 0.5 |
| Covered Calls For AnaptysBio, Inc. (ANAB) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| May 17 | 20 | 1.05 | 32.51 | -38.5% | -638.7% | |
| Jun 21 | 20 | 1.20 | 32.36 | -38.2% | -244.6% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
AnaptysBio, Inc., a clinical stage biotechnology company, engages in developing antibody product candidates focused on unmet medical needs in inflammation. The company's proprietary anti-inflammatory pipeline includes ANB020, an anti-interleukin-33 antibody for the treatment of moderate-to-severe adult atopic dermatitis, severe adult peanut allergy, and severe adult eosinophilic asthma; ANB019, an anti-interleukin-36R antibody for the treatment of rare inflammatory diseases, including generalized pustular psoriasis and palmo-plantar pustular psoriasis; and a portfolio of checkpoint receptor agonist antibodies for the treatment of certain autoimmune diseases. It also has an immuno-oncology partnership with TESARO, Inc. and TESARO Development, Inc. to develop and commercialize monospecific antibody product candidates targeting TIM-3 (TSR-022), LAG-3 (TSR-033), and PD-1 (TSR-042), as well as a bispecific antibody product candidate targeting PD-1 and LAG-3; and an inflammation partnership with Celgene Corporation to develop an anti-PD-1 agonist antibody (CC-90006) that is in Phase 1 trial. The company was formerly known as Anaptys Biosciences, Inc. and changed its name to AnaptysBio, Inc. in July 2006. AnaptysBio, Inc. was founded in 2005 and is based in San Diego, California.
| Top 10 Open Interest For May 17 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | IWM covered calls | 6. | EEM covered calls | 1. | WOLF covered calls | |
| 2. | HYG covered calls | 7. | KWEB covered calls | 2. | ENVX covered calls | |
| 3. | QQQ covered calls | 8. | SLV covered calls | 3. | FSLY covered calls | |
| 4. | SPY covered calls | 9. | TSLA covered calls | 4. | NOVA covered calls | |
| 5. | FXI covered calls | 10. | NVDA covered calls | 5. | COIN covered calls | |
Want more examples? AN Covered Calls | ANDE Covered Calls
